Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



Lilly reports full Q4 2024 financial results and provides 2025 guidance

February 10, 2025
Eli Lilly and Company has recently released its financial results for the fourth quarter of 2024 along with its guidance for the year 2025. The pharmaceutical giant reported strong growth in its revenue, exceeding expectations and showcasing its ability to adapt and succeed in the face of challenges. Despite a slight decline in weight loss diabetes drug sales, Eli Lilly managed to beat earnings estimates, reflecting the company's diverse product portfolio and commitment to innovation. Looking ahead, the company provided an optimistic outlook for 2025, projecting further growth and advancements in its pipeline of therapies. With a solid performance and promising future prospects, it could be worth considering the opinion of professionals at Stocks Prognosis for an expert forecast on the movement of Eli Lilly's stock.

Find out how the ELI LILLY AND COMPANY rate is expected to change

Get Forecast for LLY

Investor opinions & comments:

Eli Lilly's continued advancements in therapies and research give me hope for the future of healthcare
— from TraderTobias at 02-13-2025 12:16
Eli Lilly's commitment to innovation and diverse product portfolio give me confidence in their long-term growth
— from MarketMason at 02-13-2025 12:14
The strong performance of Eli Lilly's stock reflects the company's resilience and strategic approach
— from CalebBishop at 02-13-2025 12:10
It's impressive to see Eli Lilly's revenue growth exceeding expectations. They must be doing something right
— from MoneyMartha at 02-13-2025 04:16
I have high hopes for Eli Lilly's future. They have proven their ability to adapt and excel in a challenging market
— from TylerGonzalez at 02-13-2025 03:39
I trust the professionals at Stocks Prognosis to provide an expert forecast on the movement of Eli Lilly's stock
— from MoneyMandy at 02-12-2025 23:23
Eli Lilly's solid Q4 results and positive outlook for 2025 demonstrate their ability to navigate challenges in the pharmaceutical industry
— from SavingsSandy at 02-12-2025 07:06
I have confidence in Eli Lilly's leadership to continue driving growth and success in the coming years
— from JeremiahSnyder at 02-12-2025 05:47
I'm eager to hear more about Eli Lilly's pipeline of therapies and advancements in the coming year
— from SadieColeman at 02-12-2025 05:09
Great news! I'm excited to see Eli Lilly's strong growth and optimistic outlook for 2025
— from CharlesGrant at 02-12-2025 00:12
Eli Lilly's financial results and guidance show that they are on the right track for future success
— from CashKendra at 02-11-2025 17:25
The positive financial results and optimistic outlook make me believe that Eli Lilly's stock could be a smart investment
— from JosephMorris at 02-11-2025 14:15
I'm not sure if Eli Lilly can sustain this level of growth. The decline in weight loss diabetes drug sales is concerning
— from JessicaMoore at 02-11-2025 12:31
I'm not convinced that Eli Lilly's diverse product portfolio can make up for the decline in one of their major sales categories
— from MoneyMartha at 02-10-2025 19:08
I'm skeptical about Eli Lilly's guidance for 2025. It's hard to predict the future of the pharmaceutical industry
— from SavingsSam at 02-10-2025 17:07
I'm optimistic about Eli Lilly's future prospects. Their ability to adapt and succeed sets them apart from other pharmaceutical companies
— from NicholasEdwards at 02-10-2025 12:54
Eli Lilly's strong growth in revenue highlights their ability to meet the demands of the market and drive success
— from GrowthGreg at 02-10-2025 12:42
Eli Lilly's ability to beat earnings estimates shows their strength as a company and their commitment to innovation
— from StockSteve at 02-10-2025 08:38
I'm looking forward to seeing the advancements and breakthroughs that Eli Lilly will bring in 2025
— from PennyParker at 02-10-2025 07:04
If you want to leave a comment, then you need Login or Register





Other news for LLY

LLYMarch 22, 2025Eli Lilly and Company LLY: Leading the Way in Pharmaceutical Innovation  ~2 min.

Eli Lilly and Company (LLY) continues to make waves in the pharmaceutical industry with its innovative and groundbreaking therapies....

LLYMarch 19, 2025Eli Lilly and Company LLY Surges After Breakthrough BRAVE-AA-PEDS Study Results  ~2 min.

Eli Lilly and Company (LLY) has recently made a significant breakthrough in its BRAVE-AA-PEDS study, resulting in a surge of investor attention and market gains....

LLYMarch 18, 2025Eli Lilly and Company: A Promising Investment in the Pharma Industry  ~1 min.

Eli Lilly and Company (LLY) has been making waves in the pharmaceutical industry with its innovative products and strong performance....

LLYMarch 17, 2025Eli Lilly and Company's Groundbreaking Discovery Revolutionizes Pharma Industry  ~2 min.

Eli Lilly and Company, a renowned pharmaceutical giant, has recently made a groundbreaking discovery that is set to revolutionize the entire industry....

LLYMarch 16, 2025Is Eli Lilly and Company LLY Set to Revolutionize the Pharma Industry?  ~2 min.

Eli Lilly and Company (LLY) has been making headlines recently with its groundbreaking research and innovative products....



Related news

VRTXJanuary 12, 2025Vertex Pharmaceuticals Incorporated Faces Setbacks in Clinical Trials  ~1 min.

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) shares experienced a slide recently due to setbacks in its clinical trials....

AMGNFebruary 26, 2025Amgen Inc. AMGN: Among the Cheap Pharmaceutical Stocks to Buy According to Analysts  ~1 min.

Analysts have identified Amgen Inc. (NASDAQ:AMGN) as one of the cheap pharmaceutical stocks to buy....

REGNMarch 16, 2025JIM CRAMER ENCOURAGES INVESTORS TO OWN REGENERON PHARMACEUTICALS INC.  ~2 min.

In the latest episode of Mad Money, renowned financial expert Jim Cramer expressed his bullish stance on Regeneron Pharmaceuticals Inc. (REGN)....

REGNJanuary 2, 2025Regeneron Pharmaceuticals Continues to Impress Investors with Strong Returns  ~1 min.

In the past five years, Regeneron Pharmaceuticals (NASDAQ:REGN) has delivered a solid return of 89%, making it a favorable choice for investors....

REGNFebruary 10, 2025Regeneron Pharmaceuticals Inc REGN Q4 2024 Earnings Call Highlights: Strong Revenue Growth ... Yahoo Finance  ~1 min.

Regeneron Pharmaceuticals Inc. (REGN) recently held its Q4 2024 earnings call, highlighting strong revenue growth and positive developments in its portfolio....